April 17, 2026 10:22 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Panic reaction’: Rahul Gandhi on women’s bill, says PM Modi ‘wants to send a message’ | Adani Group shares rise as Gautam Adani becomes Asia’s richest, overtakes Mukesh Ambani | TCS Nashik ‘conversion’ case accused seeks anticipatory bail citing pregnancy | IT raids TMC candidate Debasish Kumar’s premises ahead of Bengal polls | Bengal SIR: Supreme Court allows voters restored by tribunal till April 21 and 27 to vote | 'Women won't spare you': PM Modi warns Opposition over resistance to quota bill | Vijay booked in 3 cases over poll code violation ahead of Tamil Nadu polls | 'Black law': Stalin burns copy of 'delimitation' bill, slams Modi govt | TCS halts Nashik BPO operations amid sexual abuse, conversion allegations | ‘We are surprised’: SC stays Pawan Khera’s bail over remarks on Himanta Biswa Sarma’s wife
Moderna

Moderna Covid-19 vaccine likely to protect for 'couple of years': CEO Stephane Bancel

| @indiablooms | Jan 08, 2021, at 05:40 am

Paris/IBNS: Moderna's COVID-19 mRNA vaccine is expected to offer protection of up to a couple of years, the US biotech's chief executive said on Thursday.

The US biotech company, which came up with a vaccine last year against the novel coronavirus in just a few weeks, received approval for its shot from the European Commission on Wednesday, reports said.

Speaking at an event, organised by financial services group Oddo BHF, Moderna CEO Stephane Bancel said: "The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window."

"The antibody decay generated by the vaccine in humans goes down very slowly (...) We believe there will be protection potentially for a couple of years," he said, as reported by Reuters.

Bancel said his country is working to prove that its vaccine would also be effective against variants of the coronavirus seen in Britain and South Africa.

Scientists claim that the newly developed vaccines should be effective against both variants.

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.